SciCombinator

Discover the most talked about and latest scientific content & concepts.

A Blauvelt, K Reich, TF Tsai, S Tyring, F Vanaclocha, K Kingo, M Ziv, A Pinter, R Vender, S Hugot, R You, M Milutinovic and D Thaçi
Abstract
Secukinumab demonstrated superior efficacy to ustekinumab at week 4 and week 16 of the CLEAR study, with comparable safety, in subjects with moderate-to-severe plaque psoriasis.
Tweets*
10
Facebook likes*
0
Reddit*
0
News coverage*
11
Blogs*
0
SC clicks
0
Concepts
Clear, Tetrahydrogestrinone, Clearing, Ustekinumab, Psoriasis
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com